Репозиторий Университета

Metabolomic profiling of patients with cardiovascular diseases

  • Belenkov Y.
  • Privalova E.
  • Kozhevnikova M.
  • Korobkova E.
  • Ilgisonins I.
  • Kaplunova V.
  • Shakaryants G.
  • Appolonova S.
  • Kuharenko A.
  • Larcova E.
  • Mesonzhik N.
Дата публикации:01.01.2018
Журнал: Kardiologiya
БД: Scopus
Ссылка: Scopus


© 2018 Media Sphera Publishing Group. All rights reserved. Cardiovascular diseases (CVD) are the main cause of death worldwide. A broad study of the pathogenetic mechanisms of the CVD onset and progression has led to understanding of the importance of endothelial dysfunction (ED) in these processes. During recent years intensive work has been conducted in the direction of searching for markers of ED. Metabolomics is an intensively advancing approach to early diagnostics of diseases. Metabolomic analysis based on mass spectrometry allows to study complete metabolic profiles and their deviations resulting from changes in expression of genes and RNA, protein activity, or environmental factors. Metabolomic analysis has already demonstrated significant results in the solving of different scientific and clinical problems. It appears to be a promising method for detecting early biomarkers of CVD. Various aspects of application of metabolomic profiling in the field of cardiovascular diseases are discussed in this article.

Вернуться назад